Eplerenone Inhibits Atrial Autonomic Nerve Remodeling in Atrial Fibrillation Through ERK1/2 MAPK Pathway. [PDF]
Xu W +10 more
europepmc +1 more source
UNI-494 treatment improves measures of renal dysfunction and cardiac pathology in male rats receiving L-NAME and angiotensin II. [PDF]
Ho FJM +9 more
europepmc +1 more source
Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction. [PDF]
Kobayashi M +10 more
europepmc +1 more source
Recent advances in mineralocorticoid receptor antagonists for heart failure with preserved ejection fraction: focus on finerenone in the era of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. [PDF]
Wang TY, Zhang L, Wang HY, Jiang FF.
europepmc +1 more source
Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS‐HF trial [PDF]
João Pedro Ferreira +10 more
openalex +1 more source
Efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a meta-analysis of randomized controlled trials. [PDF]
Wu J, Pei Y, Wu J, Huang Y.
europepmc +1 more source
55 Eplerenone benefit in patients with elevated baseline heart rate in the EPHESUS trial
H J Dargie +4 more
openalex +2 more sources
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial† [PDF]
Chris Adamopoulos +8 more
openalex +1 more source
Mineralocorticoid receptor antagonists for acute myocardial infarction: a systematic review and meta-analysis of randomised controlled trials. [PDF]
Ang SP +7 more
europepmc +1 more source
Eplerenone as a treatment for resistant hypertension in pregnancy [PDF]
Jessica Gehlert, Adam Morton
openalex +1 more source

